Blue Star Capital plc
17 June 2005
For immediate release 17 June 2005
BLUE STAR CAPITAL PLC
('Blue Star' or 'the Company')
Investment in Medcenter Holdings Inc.
Blue Star Capital plc (AIM: BLU), the company created to provide seed capital
for early stage companies, is pleased to announce it has taken a minority stake
in Medcenter Holdings Inc. ('Medcenter'), a leading provider of e-marketing
intelligence and relationship marketing solutions to the pharmaceutical
industry.
Medcenter's clients include a number of the world's top five pharmaceutical
companies, in addition to other well-known multi-national pharmaceutical groups.
Medcenter focuses on improving communication between the pharmaceutical industry
and the medical community with emphasis on increasing the knowledge of
physicians and clinicians about the use of pharmaceutical products and about
treatments and disease management.
Medcenter's solutions comprise programs that augment the marketing activities of
pharmaceutical companies by making intensive use of business intelligence,
allowing pharmaceutical companies to reach hundreds of thousands of physicians,
one at a time in a highly targeted manner.
Medcenter is chaired by Michael Fitzgerald who was co-founder and chairman of
Gemini Genomics plc, prior to its merger with Sequenom Inc. Michael is also
co-founder and chairman of Block Shield Corporation plc.
Medcenter operates in more than 10 countries in Latin America, and has
subsidiaries in Brazil, Argentina, Mexico and Australia.
Blue Star is investing $462,000 in Medcenter, a private company, in return for a
minority stake.
ENDS
For further information:
Blue Star Capital plc Tel: 020 7070 7283
Nigel Robertson, Chairman
Haresh Kanabar, Chief Executive
Panmure Gordon & Co Tel: 020 7459 3600
Jonathan Retter
Katherine Roe
Buchanan Communications Tel: 020 7466 5000
Mark Court
Elly Williamson
Notes for editors
About Blue Star Capital plc
Blue Star Capital plc was formed in 2004 as a vehicle to provide initial seed
capital for the development of early stage companies. The Company joined the AIM
market of the London Stock Exchange, under the ticker symbol BLU, in October
2004 and has since made significant investments in four newly formed companies:
India Outsourcing Services plc, Black Raven Properties plc, Gordian plc and
Gasol plc. All of these companies have been admitted to the AIM market and
highlight the Company's strategy of making investments across a variety of
sectors.
Blue Star has a highly capable Board, led by Executive Chairman Nigel Robertson,
with significant experience of identifying, evaluating and securing business
opportunities and of forming, funding and floating companies.
Blue Star intends to achieve capital appreciation from a portfolio of quoted and
unquoted investments in businesses that offer strong growth prospects and a
defined timeframe to exit.
This information is provided by RNS
The company news service from the London Stock Exchange MLTMMBBBTA
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.